There is a noticeable financial burden placed on cancer patients in Pennsylvania due to an insurance provision that considers oral chemotherapy pills a pharmacy benefit. This requires the patient to pay a percentage of the cost of the pills. IV medications are considered a medical benefit, and therefore the cost is limited to co-pays. Pennsylvania lags behind 34 other states that have passed legislation to fix this disparity.